Parenteral Drugs (PDPL)
Market Closed
17 Jul, 10:00
XNSE XNSE Primary ₹
2. 90
0
0%
₹
86.47M Market Cap
- P/E Ratio
- Div Yield
1,063 Volume
0 Eps
₹ 2.9
Previous Close Want to track PDPL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Parenteral Drugs (PDPL) Statistics
Valuation metrics
Market Cap 86.47M
Enterprise value 1.17B
Trailing P/E (ttm) -0.11
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 1.19
Price/Book (mrq) -0.01
Enterprise Value/Revenue 13.81
Enterprise Value/EBITDA 3.15
Overview
Shares outstanding 29.82M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 106
Average volume (90 days) 35
Price summary
52-Week low 2.9
52-Week high 2.9
Beta -
50-Day moving average 2.9
200-Day moving average 2.9
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:1
Last split Date 13 Sep 2010
Financials
Fiscal year
Fiscal year ends 31 Mar 2022
Most recent quarter (mrq) 31 Mar 2022
Profitability
Profit margin -8.99%
Operating margin -0%
Operational effectiveness
Return on assets -0.16%
Return on equity 0.1%
Income Statement
Revenue (ttm) 84.96M
Revenue per share (ttm) 2.85
Quarterly revenue growth (yoy) 0.23%
Gross profit (ttm) 30.31M
EBITDA -
Net income to common (ttm) -763.62M
Diluted EPS (ttm) -25.61
Quarterly earnings growth (yoy) -0.31%
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0
Total debt (mrq) 1.07B
Total Debt/Equity (mrq) -0.13
Current ratio (mrq) 0.06%
Book value per share (mrq) -276.32
Cash Flow
Cash flow statement 86.09M
Levered free cash flow (LFCF) -763.62M
